Electronic Register on Advanced Heart Failure and Transplantation
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- Hospitalization for cardiovascular cause
研究概览
简要总结
The goal of this observational study is to create an electronic registry of patients diagnosed with Advanced Heart Failure or Heart Transplant, starting from 01/01/1985 and to assess the incidence of Advanced Heart Failure and Heart Transplant, and characterize patients affected by the first or undergoing the second procedure, starting from 01/01/1985. The primary outcomes are:
- Hospitalization for cardiovascular cause
- Death
详细描述
Heart failure is a pathological condition characterized by high morbidity and mortality, and it leads to a significant worsening of the quality of life for patients. The treatment of heart failure involves various options; the goal is to slow down the progression of the disease, reduce hospitalizations, increase survival, and reduce symptoms in order to improve the quality of life. Treatments range from pharmacological therapy to lifestyle changes, from device implantation to heart transplant surgery. Early diagnosis and treatment often help reduce symptoms, and many patients with heart failure can return to an active life. Patients with heart failure must undergo regular check-ups to assess their general physical condition and the status of the disease. It is therefore essential to evaluate and systematize the different therapies.
This study is both retrospective and prospective
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥ 18 years
- •Ability to provide informed consent
- •Diagnosis of Advanced Heart Failure or Heart Transplant
排除标准
- 未提供
结局指标
主要结局
Hospitalization for cardiovascular cause
时间窗: 5 years
Hospitalization for cardiovascular cause
Death
时间窗: 5 years
Death
次要结局
- Hospitalization for non-cardiovascular cause(5 years)
- Implantation of medical device (including mechanical support)(5 years)
- Need for intravenous diuretic therapy(5 years)
- Need for hemodialysis event(5 years)